Medicare Enrolled
Dr. Larisa Kayserman, MD
Retina Specialist (Ophthalmology) Physician · Ridgewood, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kayserman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kayserman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kayserman
Dr. Larisa Kayserman is a retina specialist physician in Ridgewood, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kayserman performed 22,041 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kayserman received a total of $5,146 from 25 pharmaceutical and/or device companies across 75 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kayserman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 32% volume in NJ
$5,146 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗22,041
Medicare services
Top 32% in NJ for retina specialist (ophthalmology) physician
Not available
Unique patients (not deduplicated)
$143
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
7,320 | $29 | $41 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
3,447 | $33 | $98 |
| Aflibercept eye injection (Eylea) | 2,870 | $689 | $951 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
1,925 | $21 | $73 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
1,751 | $104 | $171 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
961 | $101 | $198 |
| Pegcetacoplan intravitreal injection, 1 mg An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram. |
930 | $120 | $160 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
798 | $75 | $197 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
485 | $42 | $85 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
284 | $66 | $153 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
220 | $33 | $85 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
206 | $78 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
197 | $133 | $249 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
168 | $105 | $201 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
135 | $126 | $221 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
88 | $1,744 | $2,427 |
| Retinal laser destruction of growth A laser procedure used to destroy abnormal growths in the retina. |
80 | $460 | $696 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
76 | $91 | $200 |
| Retinal membrane and internal limiting membrane removal A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina. |
22 | $861 | $1,362 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
20 | $129 | $214 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
16 | $29 | $100 |
| Removal of eye fluid | 15 | $109 | $149 |
| New patient office visit, complex (60-74 min) | 14 | $183 | $296 |
| Retinal photocoagulation to prevent detachment This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye. |
13 | $210 | $323 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,146
Total received (2018-2024)
Avg $735/year across 7 years
Top 41% in NJ for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
75
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$894
2023
$776
2022
$329
2021
$410
2020
$934
2019
$1,224
2018
$580
Payments by company (2024)
Apellis Pharmaceuticals, Inc.
$319
Bausch & Lomb Americas Inc.
$252
Regeneron Healthcare Solutions, Inc.
$144
Astellas Pharma US Inc
$123
Alimera Sciences, Inc.
$40
ABBVIE INC.
$17
Top 3 companies account for 80.0% of 2024 payments
All-time payments by company (2018-2024) ›
Bausch & Lomb Americas Inc.
$493
Allergan, Inc.
$486
Allergan Inc.
$484
Regeneron Healthcare Solutions, Inc.
$464
Apellis Pharmaceuticals, Inc.
$447
Bausch & Lomb, a division of Bausch Health US, LLC
$386
Novartis Pharmaceuticals Corporation
$359
Alcon Vision LLC
$255
Glaukos Corporation
$247
Horizon Therapeutics plc
$224
Johnson & Johnson Surgical Vision, Inc.
$217
Sun Pharmaceutical Industries Inc.
$165
BioTissue Holdings, Inc.
$161
Sight Sciences, Inc.
$133
NotalVision
$124
Astellas Pharma US Inc
$123
RxSight Inc
$108
NEW WORLD MEDICAL,INC.
$107
Biogen, Inc.
$46
Alimera Sciences, Inc.
$40
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
ABBVIE INC.
$17
Mallinckrodt Hospital Products Inc.
$15
Aerie Pharmaceuticals, Inc.
$15
Genentech USA, Inc.
$14
Top 3 companies account for 28.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Ahmed Glaucoma Valve · BEOVU · BROMSITE · CEQUA · COMBIGAN · CRYSTALENS · Cequa · Clareon · DURYSTA · ENVISTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ForeseeHome · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · Izervay · LOTEMAX SM · LUMIGAN · MIEBO · OMNI SURGICAL SYSTEM · OZURDEX · PROKERA · PROLENSA · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · Rhopressa · SUSVIMO · Syfovre · TEPEZZA · Tecnis 1-piece IOL · VYZULTA · YUTIQ · enVista MX60 IOL · iStent inject Trabecular Micro-Bypass Stent System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Retina specialist physicians in nearby ZIP areas
46
County median income
$123,715
Nearest hospital to ZIP centroid (approximate)
RAMAPO RIDGE BEHAVIORAL HEALTH HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kayserman is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kayserman experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Kayserman performed 7,320 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kayserman receive payments from pharmaceutical companies?
Yes. Dr. Kayserman received a total of $5,146 from 25 companies across 75 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kayserman's costs compare to other retina specialist physicians in Ridgewood?
Dr. Kayserman's average Medicare payment per service is $143. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kayserman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Retina Specialist Physicians in Ridgewood
Browse retina specialist physicians in Ridgewood ranked by procedure volume and transparency data.
Highest volume
Top Retina Specialist Physicians in NJ
Retina specialist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Retina Specialist Physicians in NJ
Which NJ retina specialist physicians receive the most from drug and device companies.
By company
Bausch & Lomb Americas Inc. Payments to Doctors
See all physicians who received payments from Bausch & Lomb Americas Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology